| Financial Year |
March 31 2023 |
| Monetary Funds |
1,118,168,284.58 |
| Held-for-trading Financial Assets |
68,810,655.40 |
| Notes Receivable |
37,574,173.87 |
| Accounts Receivable |
2,383,830,311.80 |
| Advances to Suppliers |
59,132,747.03 |
| Other Receivables |
217,924,252.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
535,158,798.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
45,596,496.09 |
| Total Current Assets |
7,423,093,714.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,371,815.54 |
| Long-term Equity Investment |
87,048,650.75 |
| Investment Properties |
142,754,647.80 |
| Fixed Assetes |
322,441,885.81 |
| Under-construction Projects |
557,430,659.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
276,094,101.50 |
| R&D expenses |
613,446.62 |
| Goodwill |
185,483,983.37 |
| Long-Term Deferred and Prepaid Expenses |
6,650,778.68 |
| Deferred Income Tax Assets |
9,948,495.68 |
| Other Non-Current Assets |
104,147,255.58 |
| Sub-Total of Non-Current Assets |
1,753,693,835.06 |
| Total Assets |
9,176,787,549.74 |
| Short-Term Loans |
1,681,353,729.35 |
| Trading Financial liabilities |
-- |
| Notes Payable |
203,401,787.53 |
| Accounts Payable |
1,035,995,143.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
55,486,110.93 |
| Taxes Payable |
345,037,977.33 |
| Interest Payable |
-- |
| Dividend Payable |
12,145,086.66 |
| Other payables |
225,167,753.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
58,100,431.99 |
| Other Current Liabilities |
183,653,770.70 |
| Sub-Total of Current Liabilities |
3,957,572,424.69 |
| Long-term Loans |
275,104,704.13 |
| Bonds Payable |
954,047,269.55 |
| Long-Term Accounts Payable |
194,868,981.84 |
| Special Payable |
-- |
| Estimatied Liabilities |
32,316,340.64 |
| Deferred Income Tax Liabilities |
8,915,578.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,513,042,488.63 |
| Total Liabilities |
5,470,614,913.32 |
| Paid-In Capital(Or Share Stock) |
713,598,600.00 |
| Capital Surplus |
1,270,160,558.55 |
| Surplus Reserve |
159,381,925.31 |
| LESS:Treasury Stock |
4,996,425.00 |
| Undistributed Profits |
1,242,056,727.52 |
| Minority Stockholder's Interest |
95,213,559.38 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,610,959,077.04 |
| Owner's Equity（Stockholder's Equity） |
3,706,172,636.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,176,787,549.74 |
